Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
600161.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.23
-27%
0.18
vs 0.25
Q3.23
+50%
0.19
vs 0.13
Q4.23
-41%
0.14
vs 0.23
Q1.24
-12%
0.19
vs 0.22
Q2.24
+14%
0.21
vs 0.18
Q3.24
-18%
0.16
vs 0.19
Q4.24
+85%
0.25
vs 0.14
Q1.25
-38%
0.12
vs 0.19
Q2.25
-4%
0.2
vs 0.21
Q3.25
+51%
0.24
vs 0.16
Sales Growth
YoY
Current
Estimates
Q2.23
+18%
1.4B vs 1.2B
Q3.23
+30%
1.3B vs 1B
Q4.23
-15%
1.1B vs 1.3B
Q1.24
-6%
1.2B vs 1.3B
Q2.24
+16%
1.6B vs 1.4B
Q3.24
-7%
1.2B vs 1.3B
Q4.24
+70%
2B vs 1.1B
Q1.25
+9%
1.3B vs 1.2B
Q2.25
-5%
1.5B vs 1.6B
Q3.25
+63%
2B vs 1.2B
Return on Equity
QoQ
Q2.23
+3%
0.03
vs 0.04
Q3.23
+3%
0.03
vs 0.03
Q4.23
+2%
0.02
vs 0.03
Q1.24
+3%
0.03
vs 0.02
Q2.24
+3%
0.03
vs 0.03
Q3.24
+3%
0.03
vs 0.03
Q4.24
+4%
0.04
vs 0.03
Q1.25
+2%
0.02
vs 0.04
Institutionnal Ownership
Quote Panel
Key Metrics
Forecast
478%2026-Revenue
700%2026-EPS
633%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and consulting of blood products in China. Its products include blood intravenous injection immunoglobulin; blood human albumin; blood system intravenous injection; hepatitis B, freeze-dried hepatitis B, and tetanus human immunoglobulin; human immunoglobulin; and other blood products. The company was incorporated in 1998 and is headquartered in Beijing, China. Beijing Tiantan Biological Products Co., Ltd. operates as a subsidiary of China National Biotec Group Company Limited.
SHH
-0.04Â ( -0.20%)
Relative Strenght
Volume Buzz
-28%
Earning Acce
No
Dist 52w H.
29%Relative Strength
600161.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 600161.SS compares to sector?